Back to Search
Start Over
Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study
- Source :
- The Lancet Regional Health - Western Pacific; 20230101, Issue: Preprints
- Publication Year :
- 2023
-
Abstract
- The efficacy and safety of the oral Janus kinase inhibitor peficitinib were investigated in Asian patients with rheumatoid arthritis (RA).
Details
- Language :
- English
- ISSN :
- 26666065
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- The Lancet Regional Health - Western Pacific
- Publication Type :
- Periodical
- Accession number :
- ejs64042594
- Full Text :
- https://doi.org/10.1016/j.lanwpc.2023.100925